Free Trial
NASDAQ:SWTX

SpringWorks Therapeutics (SWTX) Stock Price, News & Analysis

SpringWorks Therapeutics logo
$46.99 0.00 (0.00%)
As of 07/1/2025

About SpringWorks Therapeutics Stock (NASDAQ:SWTX)

Key Stats

Today's Range
$46.99
$46.99
50-Day Range
$46.46
$46.99
52-Week Range
$28.21
$62.00
Volume
N/A
Average Volume
2.66 million shs
Market Capitalization
$3.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.57
Consensus Rating
Hold

Company Overview

Receive SWTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SWTX Stock News Headlines

Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
See More Headlines

SWTX Stock Analysis - Frequently Asked Questions

SpringWorks Therapeutics' stock was trading at $36.13 at the start of the year. Since then, SWTX shares have increased by 30.1% and is now trading at $46.99.

SpringWorks Therapeutics (NASDAQ:SWTX) issued its quarterly earnings data on Friday, May, 9th. The company reported ($1.11) earnings per share for the quarter, missing the consensus estimate of ($0.81) by $0.30. The company earned $49.09 million during the quarter, compared to analysts' expectations of $64.19 million. SpringWorks Therapeutics had a negative net margin of 115.60% and a negative trailing twelve-month return on equity of 51.10%.

SpringWorks Therapeutics subsidiaries include these companies: SpringWorks Subsidiary 1 Inc, SpringWorks Subsidiary 2 Inc, SpringWorks Subsidiary 3 Inc, SpringWorks Subsidiary 4 Inc, SpringWorks Therapeutics LLC, and SpringWorks Therapeutics Operating Company Inc..

SpringWorks Therapeutics (SWTX) raised $126 million in an IPO on Friday, September 13th 2019. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. ​J.P. Morgan, Goldman Sachs and Cowen​ ​ acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Top institutional shareholders of SpringWorks Therapeutics include Syquant Capital Sas (0.33%), Credit Industriel ET Commercial (0.32%), Palisades Investment Partners LLC (0.18%) and Wolverine Asset Management LLC (0.13%). Insiders that own company stock include Orbimed Advisors Llc, Saqib Islam, Badreddin Edris, Daniel Lynch, Bhavesh Ashar, Daniel Pichl and Julie Hambleton.
View institutional ownership trends
.

Shares of SWTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SpringWorks Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
5/09/2025
Today
8/05/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SWTX
CIK
1773427
Fax
N/A
Employees
230
Year Founded
2017

Price Target and Rating

High Price Target
$68.00
Low Price Target
$47.00
Potential Upside/Downside
+11.9%
Consensus Rating
Hold
Rating Score (0-4)
2.13
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$258.13 million
Net Margins
-115.60%
Pretax Margin
-115.60%
Return on Equity
-51.10%
Return on Assets
-43.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.33
Quick Ratio
4.18

Sales & Book Value

Annual Sales
$191.59 million
Price / Sales
18.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.47 per share
Price / Book
7.26

Miscellaneous

Outstanding Shares
75,350,000
Free Float
69,449,000
Market Cap
$3.54 billion
Optionable
Optionable
Beta
0.68

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:SWTX) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners